WARTICIDE

Manufacturer
The Sisquoc Healthcare Corporation
Effective date
2025-04-21
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-06-01 00:59:28

Label at a glance#

ProductWARTICIDE
Active ingredientSALICYLIC ACID
Label structure9 sections

Indications and uses

WART REMOVER

Dosage and administration

Simply unscrew the top and fill the dropper tip with liquid. Once full, apply Warticide to the wart or warts until the infected area is lightly covered with gel. Gently work Warticide into the wart with a finger and then wash hands after application is finished. Allow 3-4 minutes for the solution to absorb.

Storage and handling

Store between 20°c to 25°C (68° to 77°F)

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

SALICYLIC ACID 10%

PURPOSE

OTC - PURPOSE SECTION

WART REMOVER

USES

INDICATIONS & USAGE SECTION

  • WART REMOVER

WARNINGS

WARNINGS SECTION

FOR EXTERNAL USE ONLY.

DO NOT USE ON CHILDREN UNDER 2 YEARS OF AGE UNLESS DIRECTED BY A DOCTOR.

WHEN USING THIS PRODUCT AVOID CONTACT WITH THE EYES. IF CONTACT OCCURS, RINSE THE EYES VERY THOROUGHLY WITH WATER.

STOP USE AND ASK A DOCTOR IF IRRITATION OCCURS OR THERE IS NO IMPROVEMENT WITHIN 4 WEEKS.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN. IF SWALLOWED, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Simply unscrew the top and fill the dropper tip with liquid. Once full, apply Warticide to the wart or warts until the infected area is lightly covered with gel. Gently work Warticide into the wart with a finger and then wash hands after application is finished. Allow 3-4 minutes for the solution to absorb.

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

WATER, ETHANOL, XANTHAN GUM, MELALEUCA ALTERNIFOLIA LEAF OIL, CEDAR LEAF OIL.

STORAGE AND HANDLING SECTION

Store between 20°c to 25°C (68° to 77°F)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LabelLabel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
238465salicylic acid 10 % Topical SolutionPSN5
2267559WARTICIDE 10 % Topical SolutionPSN5
2267559salicylic acid 100 MG/ML Topical Solution [WARTICIDE]SBD5
238465salicylic acid 100 MG/ML Topical SolutionSCD5
238465salicylic acid 10 % Topical SolutionSY5
2267559Warticide 100 MG/ML Topical SolutionSY5

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71229-105-11WARTICIDE30 mL in 1 BOTTLE, DROPPERSOLUTION305

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71229-105WARTICIDE (SALICYLIC ACID) SOLUTION [THE SISQUOC HEALTHCARE CORPORATION]5Current NDC, Legacy NDC, 1 package rows20250423_d9aff395-18bb-4680-826e-e15025f73161.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71229-10571229-105-11

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
WARTICIDESALICYLIC ACIDThe Sisquoc Healthcare Corporationd9aff395-18bb-4680-826e-e15025f731612025-04-21WarningsExact identifier
ndc (package): 71229-105-11
ndc (product): 71229-105
ndc11 (package): 71229010511
spl id: 334f3c8b-dd05-b5aa-e063-6294a90a963d
spl set id: d9aff395-18bb-4680-826e-e15025f73161

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.